Skip to main content

By Market & Region

Filter fairsonline.org news by target market and region. Use the dropdown above to focus on the markets most relevant to your business.

FINN Partners Releases Brain Health eBook Amid UNGA81 Summits

Image
FINN Partners Releases Brain Health eBook Amid UNGA81 Summits

New York – – September 21, 2026 -- FINN Partners has released a new eBook, The Next Frontier in Brain Health, timed to World Alzheimer's Day and the opening of the United Nations General Assembly in New York. The collection arrives as the World Health Organization reports nearly 10 million new dementia cases develop worldwide each year, with delayed diagnoses and fragmented patient journeys leaving families without clear direction.

Collection targets the gap between scientific advances and patient care

The eBook argues that complex scientific information often fails to reach patients, caregivers and policymakers in usable form. Richard Hatzfeld, Senior Partner and global lead for FINN's Global Health Practice brain health initiatives, edited the collection and said it brings together FINN colleagues to help clients explain the science, address barriers to care and embed brain health into workplace and public policy decisions.

Infinium Launches mSAF Platform to Convert Methane Into Aviation Fuel

Image
Infinium Launches mSAF Platform to Convert Methane Into Aviation Fuel

Sacramento, Calif. – September 21, 2026 -- Infinium has introduced mSAF, a new product line that converts renewable natural gas, biogas, flare gas and other methane streams into low-carbon sustainable aviation fuel (SAF), extending the company's existing CO2-based eSAF business into a second feedstock category.

Infinium adds methane pathway to complement its CO2-based eSAF business

The mSAF platform targets methane already aggregated at landfills, dairies, wastewater facilities and gas-gathering systems across North America, Asia and Europe. CEO Robert Schuetzle said the offering lets Infinium apply its proven technology across a broader range of locations while delivering more low-carbon fuel alongside its growing eSAF operations.

Sandvik Names Nomination Committee for 2027 Annual Meeting

Stockholm – September 21, 2026 -- Sandvik AB has appointed a five-member Nomination Committee to prepare board and auditor proposals ahead of its 2027 Annual General Meeting, scheduled for April 28, 2027, in Sandviken, Sweden.

Four principal shareholders each name a representative to the committee

The committee comprises Fredrik Lundberg of AB Industrivärden, who serves as chairman; Oscar Bergman of Swedbank Robur Funds; Lars Pettersson of Lundbergs; Frank Larsson of Handelsbanken Funds; and Sandvik's own Board Chairman, Johan Molin, acting as convenor. The composition follows a standing instruction adopted at the 2020 AGM, under which the four largest shareholders by voting rights as of the last banking day in August each designate a member.

ElektraFi Connects Colorado Counties Federal Broadband Funds Bypassed

Image
ElektraFi Connects Colorado Counties Federal Broadband Funds Bypassed

Steamboat Springs, Colo. – September 21, 2026 -- ElektraFi has deployed broadband infrastructure across Routt and Moffat Counties, delivering high-reliability internet to areas that federal and state programs have consistently failed to reach.

Colorado's Middle Mile Program allocated zero funding to two counties with documented connectivity gaps

The Colorado Broadband Office's recent Middle Mile Program awards excluded Routt and Moffat Counties entirely, despite acknowledged service shortfalls in the region. ElektraFi's network already reaches critical governmental and public agencies ahead of any public capital deployment, including Yampa Valley Regional Airport, the Steamboat Springs Fire Station, and the local Water Treatment Plant.

A2Gold Reports Record 141.10 g/t Gold Intercept at Eastside's Castle Target

Image
A2Gold Reports Record 141.10 g/t Gold Intercept at Eastside's Castle Target

Tonopah, Nevada – September 21, 2026 -- A2Gold Corp. (TSXV: AUAU) (OTCQX: AUXXF) (FRA: RR7) reported the highest-grade gold assay to date at its Eastside Gold-Silver Project, with drill hole CAC-007 returning 141.10 g/t gold over 0.9 metres roughly 53 metres below surface.

Drill hole CAC-007 delivers 141.10 g/t gold, the strongest result yet at Eastside

The intercept, recorded at 75.9 metres downhole within the existing Castle mineral resource, is tied to an interpreted northeast-striking structural zone where Tertiary volcanic rocks meet Paleozoic sedimentary basement. The result sits along the same structural trend as previously reported high-grade surface samples at Black Rock, which returned 10.50 g/t Au over 0.26 metres and 5.63 g/t Au over 0.28 metres. A2Gold flagged the roughly 400-metre corridor between Black Rock and CAC-007 as incompletely tested and a priority for follow-up drilling.

Water-AI Nexus Adds Veolia, WaterISAC to Advisory Council

Image
Water-AI Nexus Adds Veolia, WaterISAC to Advisory Council

Alexandria, Va. – September 21, 2026 -- The Water-AI NexusTM Center of Excellence marked its first anniversary by adding Veolia, WaterISAC, the Water and Wastewater Equipment Manufacturer's Association, and the Rural Community Assistance Partnership to its Advisory Council, bringing the total of 2026 additions to 20 organizations.

The Center was founded by the Water Environment Federation (WEF), Amazon, The Water Center at the University of Pennsylvania, and Leading Utilities of the World to address competing pressures between AI infrastructure water demand and municipal utility resilience.

Nabsys Pairs CRISPR/Cas9 With Electronic Genome Mapping in New Study

Image
Nabsys Pairs CRISPR/Cas9 With Electronic Genome Mapping in New Study

Providence, R.I. – September 21, 2026 -- Nabsys 2.0, LLC has published the first study combining CRISPR/Cas9 with its proprietary Electronic Genome Mapping (EGM) technology, demonstrating a method to both evaluate CRISPR/Cas9 activity and direct EGM to target specific genomic regions rather than only genome-wide analysis.

The preprint, titled 'CRISPR/Cas9 Optimization Using Electronic Genome Mapping: Potential Role for Studying Human Genetic Disease,' was led by John F. Thompson, Ph.D., Principal Application Scientist at Nabsys, and posted on bioRxiv.

HEVO Joins ORNL-BMW Program to Test Polyphase Wireless EV Charging

Image
HEVO Joins ORNL-BMW Program to Test Polyphase Wireless EV Charging

Brooklyn, N.Y. – September 21, 2026 -- HEVO Inc. is contributing coil engineering and technical analysis to a bench-testing program run by Oak Ridge National Laboratory (ORNL) and BMW to evaluate next-generation polyphase wireless vehicle charging technology.

HEVO supplies circular coil topologies for BMW's compatibility testing with ORNL's proprietary polyphase system

The New York-based Tier 1 supplier is applying its patented Rezonant wireless charging hardware expertise to help BMW assess how its circular coil designs interact with ORNL's polyphase coil architecture. HEVO holds a technology license from ORNL and is providing engineering support to the joint evaluation effort.

Lazard Hires Ex-Barclays Banker Spence to Lead Defense Tech M&A

Image
Lazard Hires Ex-Barclays Banker Spence to Lead Defense Tech M&A

New York – September 21, 2026 -- Lazard, Inc. (NYSE: LAZ) has appointed Matt Spence as Head of Defense Technology and Emerging Technology within its Technology Group, based in San Francisco.

Spence brings a defense-tech banking franchise he built at Barclays

Spence most recently served as Managing Director and Global Head of Venture Capital Banking at Barclays, where he established and led the firm's defense-tech and dual-use technology investment banking practice. He will advise defense, security, and emerging technology companies on M&A transactions and financings at Lazard.

Career spans government, venture capital and banking

Before Barclays, Spence held senior roles at Guggenheim Partners and served as a Partner at Andreessen Horowitz. He spent seven years in senior U.S. national security positions, including as Deputy Assistant Secretary of Defense for Middle East Policy and on the White House National Security Council.

QIA, J.P. Morgan Asset Management Ink $20 Billion Investment Pact

Image
QIA, J.P. Morgan Asset Management Ink $20 Billion Investment Pact

Doha – – September 21, 2026 -- Qatar Investment Authority (QIA) and J.P. Morgan Asset Management (JPMAM) have signed a Memorandum of Understanding to build a USD 20 billion strategic partnership spanning public and private markets in equities and credit.

QIA Allocates $15 Billion To Customized Global Equity Mandates

The larger of the two tracks is a USD 15 billion public equities mandate under which JPMAM will manage bespoke global equity portfolios for QIA, drawing on the firm's active equity capabilities, global investment platform and research infrastructure.

$5 Billion Private Credit Push Targets U.S. Middle-Market Firms

A second USD 5 billion initiative will see QIA and JPMAM jointly provide senior financing to established middle-market companies in the United States, with sector focus on industrials, services, healthcare and technology.

Tencent's ECS Platform Runs Technical Backbone for 11 Asian Games Esports Events

Image
Tencent's ECS Platform Runs Technical Backbone for 11 Asian Games Esports Events

Tokoname, Japan – September 21, 2026 -- Tencent Esports Competition Solution (ECS) is providing end-to-end technical support across all 11 esports events at the 20th Asian Games, running September 22 to October 2 at Hall D of the Aichi Sky Expo in Japan.

Esports Programme Spans Six Game Categories and Multiple Publishers

The 20th Asian Games features esports' largest programme in the event's history, with 11 events across six game categories requiring coordination across different game engines, version management systems and device formats. ECS was built to give referees, competition operations staff and monitoring teams a consistent technical framework across this fragmented environment, covering pre-match equipment checks, real-time match monitoring and post-match review.

T-MAXIMUM's Allogeneic CAR-T Shows 80% Tumor Shrinkage in Brain Metastases

Beijing – September 21, 2026 -- T-MAXIMUM Pharmaceutical reported that two of three evaluable patients with refractory brain metastases from lung cancer achieved partial responses with roughly 80% tumor shrinkage after treatment with its allogeneic B7-H3-targeted CAR-T therapy, MT027, according to early data presented at the IASLC World Conference on Lung Cancer (WCLC 2026) in Seoul.

Two of three evaluable patients hit 80% tumor shrinkage in dose-escalation trial

In the prospective, investigator-initiated trial (ChiCTR2500107346), five patients with heavily pretreated, guideline-exhausted brain metastases completed treatment. Of the three with measurable disease, two achieved partial responses and one achieved stable disease. As of the company's September 2026 follow-up, the two responders have survived more than 11 and 13 months, respectively, since their first MT027 dose, and all three evaluable patients remain alive.

VIO Med Spa Signs Three-Unit Deal to Enter Charleston Market

Image
VIO Med Spa Signs Three-Unit Deal to Enter Charleston Market

CHARLESTON, S.C. – – September 21, 2026 -- VIO Med Spa has signed a three-unit development agreement to enter South Carolina for the first time, with the first Charleston-area location targeted to open in 2027. Site selection is currently underway.

Former CVS Health Executive Leads Local Development

Ted Loya, who spent more than 23 years at CVS Health in its pharmacy benefits business working with national employers, will spearhead the brand's build-out across the Charleston area. New to franchising and medical aesthetics, Loya cited VIO's established infrastructure, financial backing, and existing East Coast footprint in North Carolina and Georgia as deciding factors in bringing the brand to South Carolina.

Deal Extends Brand's East Coast Footprint

Ryan Rao, Chief Development Officer at VIO Med Spa, said the Charleston entry strengthens the company's presence in the Southeast and supports further expansion along the East Coast.

IGT and Everi Unveil Integrated Gaming Portfolio at G2E 2026

Image
IGT and Everi Unveil Integrated Gaming Portfolio at G2E 2026

Las Vegas – September 21, 2026 -- IGT and Everi will present a combined portfolio of slot games, casino management systems and FinTech products at the 2026 Global Gaming Expo (G2E) in Las Vegas, running Sept. 28 through Oct. 1, at booth 4455.

New titles debut on RISE32 and RISE55 cabinets

IGT will launch Lightning Rails and Split 'N' Win Link Boost on its RISE32 cabinet, both offering player-selectable denomination configurations. The RISE55 cabinet will host premium evolutions Money Gong Divine and Tiger and Dragon Power Sphere, alongside Piggz Link base games Frankenswine and Prince of Porkness, and Triple Coin Link themes Grand Buddha and Grand Cat.

Ernest Health Secures Sites for 6 NC Rehab Hospitals

Image
Ernest Health Secures Sites for 6 NC Rehab Hospitals

Mesquite, Texas – September 21, 2026 -- Ernest Health has secured development sites in six North Carolina markets for freestanding inpatient rehabilitation hospitals, marking Phase 1 of a statewide expansion program. The company controls parcels in Winston-Salem, Mooresville, Gastonia, Hickory, South Asheville/Arden and Goldsboro through development partner Summit Healthcare Group.

Six sites move from announcement to construction-ready status

Summit Healthcare Group, a Winston-Salem-based healthcare real estate firm founded in 2008 with more than 750,000 square feet of ground-up healthcare delivery experience, now holds control of all six parcels. The sites span the Piedmont Triad, the Lake Norman and Gaston County submarkets of Charlotte, the Catawba Valley, Western North Carolina and Eastern North Carolina. Each location was chosen for proximity to acute care referral sources, transportation access and local older-adult population density.

Scinai Regains Nasdaq Compliance on $1.00 Minimum Bid Price Rule

Image
Scinai Regains Nasdaq Compliance on $1.00 Minimum Bid Price Rule

Jerusalem – September 21, 2026 -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) has regained compliance with Nasdaq's $1.00 minimum bid price rule after its American Depositary Shares closed at or above that threshold for 19 consecutive business days, Nasdaq Listing Qualifications confirmed in a September 18, 2026 letter.

Nasdaq closes compliance matter after ADS price clears threshold for 19 sessions

The closing bid price of Scinai's ADSs met or exceeded $1.00 per share from August 21, 2026 through September 17, 2026, satisfying Nasdaq Listing Rule 5550(a)(2). Nasdaq had first flagged the deficiency on March 12, 2026, after the ADSs failed to maintain the $1.00 minimum over the prior 30 consecutive business days.

CEO says resolution shifts focus to CDMO commercial execution

"Receiving Nasdaq's confirmation closes an important compliance matter for Scinai,

FDA Grants Priority Review to Insmed's ARIKAYCE Full Approval Bid

Image
FDA Grants Priority Review to Insmed's ARIKAYCE Full Approval Bid

Bridgewater, N.J. – September 21, 2026 -- The U.S. Food and Drug Administration has accepted Insmed Incorporated's supplemental New Drug Application (sNDA) for full approval of ARIKAYCE (amikacin liposome inhalation suspension) to treat Mycobacterium avium complex (MAC) lung disease, granting Priority Review with a PDUFA target action date of January 28, 2027.

FDA sets January 28, 2027 decision date under Priority Review

The Priority Review designation applies to therapies that could offer significant improvement in safety or efficacy for serious conditions. Insmed said full approval would allow ARIKAYCE, administered via PARI Pharma's Lamira Nebulizer System, to reach patients earlier in their disease course, including newly diagnosed cases and those with recurrent infections.

FDA Grants Platform Designation to Precigen's AdenoVerse Tech

Image
FDA Grants Platform Designation to Precigen's AdenoVerse Tech

Germantown, Md. – September 21, 2026 -- The U.S. Food and Drug Administration has granted platform technology designation to Precigen's AdenoVerse immunotherapeutic platform, the technology underlying the company's first commercial product, PAPZIMEOS, approved in August 2025 for recurrent respiratory papillomatosis (RRP) in adults.

FDA designation opens accelerated pathway for future AdenoVerse cancer programs

The designation allows Precigen to leverage manufacturing and preclinical data generated for PAPZIMEOS to support future marketing applications for other AdenoVerse-based candidates, reducing duplicative development work. It also grants the company earlier and more frequent FDA engagement and allows regulators to consider prior manufacturing inspections when reviewing future applications.

Fluxnium Raises $7M to Extract Uranium From Seawater

Image
Fluxnium Raises $7M to Extract Uranium From Seawater

Los Angeles – September 21, 2026 -- Fluxnium, Inc. has closed a $7 million seed round led by Congruent Ventures to commercialize technology that adsorbs uranium directly from seawater, targeting a domestic alternative to mined ore for nuclear fuel supply. Constellation Technology Ventures, the venture arm of Constellation (NASDAQ: CEG), and Active Impact Investments, Canada's largest climate tech seed fund, also participated in the round.

Seawater holds roughly 1,000 times more uranium than all identified land deposits combined

Fluxnium's proprietary high-surface-area fiber, developed in partnership with a U.S. national laboratory, passively captures dissolved uranium as seawater flows through it. The fiber deploys on longline systems in open water, the same passive infrastructure used in commercial seaweed and mussel farming, then is retrieved, processed and redeployed.

enCore Energy Hires North Star for IR, Sets Verdera Share Spinoff

Image
enCore Energy Hires North Star for IR, Sets Verdera Share Spinoff

Dallas – September 21, 2026 -- enCore Energy Corp. (NASDAQ, TSXV: EU) has engaged North Star Investor Relations Inc. under a consulting agreement effective September 18, 2026, paying a monthly cash retainer of CAD $10,000 for shareholder outreach, capital markets intelligence and media coordination.

North Star retainer runs for one year with a 30-day termination clause

The initial term of the Consulting Agreement is one year, renewable by mutual agreement, and either party may terminate on 30 days' written notice. North Star is owned by Graham Farrell and operates from Toronto; the firm and its principals are at arm's length to enCore and held no company securities when the agreement was signed. The engagement remains subject to TSXV approval.